KA-3004

N/A

Report date: 2024/04/26 14:55:04

Base Information

Drug NameKA-3004
Drug Alias NameKA-3004
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Tumor necrosis factor receptor superfamily member 9Anti-PSMA
TargetsTumor necrosis factor receptor superfamily member 9Prostate-Specific Membrane Antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKYinno Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKYinno Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A